Pharma Journalist -

Molecular Templates announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the joint development of CD38-targeted engineered toxin bodies (ETBs) for the…
Read More...

Abzena has signed an antibody humanisation agreement with Tmunity Therapeutics (Tmunity), a clinical stage T cell therapy company and a leader in the development of new Chimeric Antigen…
Read More...

Propanc Biopharma announced the execution of a research collaboration agreement with the University of Jaén, Spain, for the provision of research services and scientific technical…
Read More...

Adverum Biotechnologies announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ADVM-022. ADVM-022 is a novel gene therapy candidate for the…
Read More...

AstraZeneca announced results from the BORA Phase III extension trial evaluating the long-term safety and efficacy of Fasenra (benralizumab) as an add-on maintenance treatment in…
Read More...

Just Biotherapeutics and Pandion Therapeutics announced that they have entered into an agreement for the development and cGMP clinical manufacturing by Just of Pandion’s lead program.…
Read More...

Valeo Pharma and Besins Healthcare announced a strategic agreement to commercialize Utrogestan (micronised natural progesterone; 200mg vaginal capsules) in Canada. Utrogestan is…
Read More...

Atomwise Inc. has entered into an evaluation agreement with Pfizer. Pfizer will evaluate Atomwise’s platform to identify potential drug candidates for up to three target proteins…
Read More...

Roivant Sciences announced the launch of Respivant Sciences, a biopharmaceutical company focused on improving the lives of patients suffering from serious respiratory diseases.…
Read More...

Evotec AG and Almirall announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics through a novel approach to disrupt cell…
Read More...